Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT04539470 · COMPLETED
Trial details
- NCT number
- NCT04539470
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2023-02-24
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.